Aqtual
Aqtual, Inc. is a Hayward, California precision-medicine company founded in 2019 by Diana Abdueva (Founder and CEO) and co-founder Rich Rava, developing blood-based diagnostics on a proprietary "active chromatin" cell-free DNA (cfDNA) platform. Rather than reading cfDNA for mutations alone, Aqtual captures the previously unexplored cfDNA fragments bound to active chromatin, so a single routine blood draw reports on DNA, epigenetic regulation and protein-DNA binding together — surveying on the order of 200,000 gene promoters, 400,000 enhancers, 50,000 insulators, 20,000 silencers and a million transcription-factor binding sites. Its lead product is a therapy-response prediction test for rheumatoid arthritis, evaluated in the prospective PRIMA-102 observational trial (NCT05936970), with oncology programs in leiomyosarcoma immunotherapy response and early colorectal cancer detection, and stated expansion into immunology, cardiovascular, metabolic and neurological disease. The company raised a USD 16 million Series A in October 2023 and over USD 31 million in Series B funding announced July 2025 from Bold Capital, the Bold Longevity Growth Fund, Genoa Ventures, Manta Ray Ventures and Yu Galaxy. Aqtual is a clinical-diagnostics and life-sciences business, not a software vendor: as of August 2026 it publishes no developer portal, no API documentation and no machine-readable API contract of any kind, and every /.well-known/ and contract-discovery path on aqtual.com returns 404.
Aqtual is profiled on the APIs.io network. Tagged areas include Company, Precision Medicine, Diagnostics, Liquid Biopsy, and Cell-Free DNA.
Aqtual’s developer surface includes engineering blog, support, and 12 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 4
The organization behind the API
Other 4
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.
MCP server
One button, every client — Claude, Cursor, VS Code and the rest.
https://apis.io/mcp
Tools for providers
9 MCP tools reach this
find_providersBrowse and filter every provider in the catalog.get_provider_artifactsEvery artifact this provider publishes, grouped by type.get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.get_provider_toolsEvery MCP tool they ship, with the operation each wraps.get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.get_provider_ratingPRO — composite, band, trend and facet scores.apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.resolveTurn a domain, URL or GitHub org into the provider it belongs to.find_cohortsEvery scored population of providers in the catalog.
Call it yourself
curl for this page
curl "https://apis.io/api/v1/providers/aqtual"
curl "https://apis.io/api/v1/providers?limit=25"
curl "https://apis.io/api/v1/providers/aqtual/operations?limit=25"
curl "https://apis.io/api/v1/providers/aqtual/evidence"
Discovery needs no key. Ratings and market analysis are Pro.